| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150188C Preparation for 2-(1H-1,2,4-pyrrodiazol-1) imidazolinone derivant and bactericidal activity |
| 05/19/2004 | CN1150187C Use of selective antagonists of a1b-adrenergic receptor for improvement of sexual dysfunction |
| 05/19/2004 | CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them |
| 05/18/2004 | US6737437 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/18/2004 | US6737435 Indole derivatives and their use as MCP-1 antagonist |
| 05/18/2004 | US6737425 N,N-substituted cyclic amine derivatives |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | CA2334317C Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 05/18/2004 | CA2297279C New cyano-indole compounds that inhibit serotonin recapture, the process for their preparation and the pharmaceutical compounds that contain them |
| 05/13/2004 | WO2004039894A2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 05/13/2004 | WO2004039796A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 05/13/2004 | WO2004039795A2 Amide compounds for the treatment of hyperlipidemia |
| 05/13/2004 | WO2004039784A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2004039774A2 Mitotic kinesin inhibitors |
| 05/13/2004 | WO2004039365A1 Agent for preventing or treating neuropathy |
| 05/13/2004 | WO2004039352A2 Amorphous form of losartan potassium |
| 05/13/2004 | WO2004039318A2 Anti-infective biaryl compounds |
| 05/13/2004 | US20040092770 Alpha-haloenamine reagents |
| 05/13/2004 | US20040092746 Fungicides |
| 05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 05/13/2004 | US20040092740 Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration |
| 05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/13/2004 | US20040092628 Heat and oxidation resistance; photostability; for automobile coatings, candle wax |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092563 Angiotensin II antagonists |
| 05/13/2004 | US20040092556 Aids therapy |
| 05/13/2004 | US20040092546 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 05/13/2004 | US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same |
| 05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
| 05/13/2004 | US20040092508 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 05/13/2004 | US20040092507 Melanocortin receptor agonists |
| 05/13/2004 | US20040092436 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins |
| 05/13/2004 | US20040091896 Having plurality of 5-6 membered unsaturated rings linked together by way of linker chains to form a backbone, at least some of 5-6 membered unsaturated rings carrying a ligand; DNA mimics, supports for use in oligonucleotide production |
| 05/13/2004 | US20040088802 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors |
| 05/13/2004 | DE10332232A1 Heteroaryloxy-substituierte Phenylaminopyrimidine Heteroaryloxyphenoxyalkanecarboxylic substituted Phenylaminopyrimidine |
| 05/13/2004 | DE10251170A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/13/2004 | CA2504511A1 Agent for preventing or treating neuropathy |
| 05/13/2004 | CA2504213A1 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2004 | CA2503119A1 Anti-infective biaryl compounds |
| 05/13/2004 | CA2485343A1 Mitotic kinesin inhibitors |
| 05/13/2004 | CA2484218A1 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 05/12/2004 | EP1418176A1 Pyrazole derivates, their preparation and their use in drugs |
| 05/12/2004 | EP1417204A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 05/12/2004 | EP1417200A2 Substituted 1h-dihydropyrazoles, their preparation and use |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417182A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417177A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 05/12/2004 | EP1417175A1 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates, their preparation and use |
| 05/12/2004 | EP1341785A4 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 05/12/2004 | EP1112070B1 Novel substituted triazole compounds |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | CN1496365A Herbicidal heterocyclic compound |
| 05/12/2004 | CN1496364A Substituted quinazoline derivatives and their use as inhibitors |
| 05/12/2004 | CN1496363A Process for preparation of imidazole compounds |
| 05/12/2004 | CN1496350A Improved process for preparing pure ondansetron hydrochloride dihydrate |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1495184A Substituted purine derivative, its preparation method, application and composition containing it |
| 05/12/2004 | CN1495182A Substituted diindolyl maleimide for inhibiting cell proliferation |
| 05/12/2004 | CN1495180A Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative |
| 05/12/2004 | CN1495172A Irreversible inhibitor of tyrosine kinase |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495170A Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1494829A Antimicrobial additive and ink composition containing said additive |
| 05/12/2004 | CN1149210C Thrombin inhibitors |
| 05/12/2004 | CN1149209C Triazole compounds with dopamine-D3-receptor affinity |
| 05/12/2004 | CN1149206C Intermediate compound for preparing xibo ketone |
| 05/12/2004 | CN1149200C 2-[(dihydro)pyrazole-3'-oxymethoylene]aniline amide and its preparation and use |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/12/2004 | CN1149083C Pharmaceutical compositions containing irbesartan |
| 05/12/2004 | CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 05/11/2004 | US6734304 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives |
| 05/11/2004 | US6734302 Cis-imidazolines |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734201 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734176 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
| 05/11/2004 | CA2156481C 5-ht2 receptor antagonist compositions useful in treating venous conditions |
| 05/11/2004 | CA2083436C Process for the preparation of 5-substituted cytosines and other 4,5-disubstituted pyrimidin-2(1h)-ones, and intermediates arising in the course of this |
| 05/06/2004 | WO2004037820A1 Oxindole substituted piperazine derivatives |
| 05/06/2004 | WO2004037818A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 05/06/2004 | WO2004037814A1 Indazolinone compositions useful as kinase inhibitors |
| 05/06/2004 | WO2004037813A1 Pyrrolidin-2-on derivatives as ep4 receptor agonists |
| 05/06/2004 | WO2004037812A1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 05/06/2004 | WO2004037809A1 Triazole compounds for the treatment of dysmenorrhoea |
| 05/06/2004 | WO2004037797A2 2 - alkyl - (2 - amino - 3 - aryl - propionyl) - piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 05/06/2004 | WO2004037788A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases |
| 05/06/2004 | WO2004037787A1 1-phenylpyrrolidine-2-one-3-carboxamides |
| 05/06/2004 | WO2004037786A2 2-pyrrolidones as ep4 receptor agonists |
| 05/06/2004 | WO2004037784A2 Pyrrolidones with anti-hiv activity |
| 05/06/2004 | WO2004037247A1 Oxindoles with anti-hiv activity |
| 05/06/2004 | WO2004037171A2 Mitotic kinesin inhibitors |